following the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines. Causes: Risk Factors: One of the most concerning aspects of CKD is its often-asymptomatic nature, particularly in early ...

Medscape Nephrology is pleased to present the KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (CKD), which was published as a supplement to ...

While previously KDOQI guidelines called out specified ranges ideal for patients with CKD, especially those on dialysis, updates steer clinicians more toward the normal range for serum phosphate ...

In 2020, the KDOQI (Kidney Disease Outcomes Quality Initiative ... (or low), refer out to a renal dietitian. Many of the root causes of high potassium can be resolved with a nutrition approach.

The guideline notes that “although restriction of sodium and/or fluids is appropriate in children with CKD associated with sodium and water retention, the most common causes of CKD in children ...

Quest Diagnostics, the world's leading provider of diagnostic information services, announced its support of the updated global version of the National Kidney Foundation Kidney Disease Outcomes ...

We assess the impact of using estimated (e)GFR to define CKD and critique published analyses of the global frequency of CKD, as defined using KDOQI ... from other causes increased by 3%.

Part 1 outlined its prevalence, causes, signs and symptoms ... Outcomes Quality Initiative guidance from the National Kidney Foundation (NKF-KDOQI, 2006) defined anaemia in CKD as a haemoglobin ...

Keryx announced the launch of Auryxia (ferric citrate) tablets to control serum phosphorous levels in patients with chronic kidney disease (CKD ... levels within the KDOQI guidelines range ...